Jack H Nunberg

Title: Jack H Nunberg: Innovator in Herpes Virus Research

Introduction

Jack H Nunberg is a notable inventor based in San Carlos, California. He has made significant contributions to the field of virology, particularly in the study of herpes viruses. His innovative work has led to advancements in the development of vaccines and therapeutic methods.

Latest Patents

Jack H Nunberg holds a patent for "Herpes virus thymidine kinase-encoding DNA." This patent describes methods for isolating thymidine kinase-encoding DNA of a herpes virus. The methods utilize degenerate primers based on regions of relatively conserved amino acid sequences in herpes virus thymidine kinase proteins. This polymerase chain reaction technique yields large amounts of thymidine kinase-encoding DNA. The patent illustrates the isolation of the thymidine kinase gene of feline herpes virus, which can be used to construct recombinant thymidine kinase-negative feline herpes viruses for live vaccines and expression vectors. Additionally, the regulatory elements of the feline herpes virus thymidine kinase gene are useful in constructing recombinant DNA vectors.

Career Highlights

Jack H Nunberg has had a distinguished career, working at The Upjohn Company. His research has focused on the genetic aspects of herpes viruses, contributing to the understanding and treatment of viral infections. His innovative approaches have paved the way for new methodologies in vaccine development.

Collaborations

Throughout his career, Jack has collaborated with notable colleagues, including Leonard Edwin Post and Teresa Compton. These collaborations have enhanced the scope and impact of his research in the field of virology.

Conclusion

Jack H Nunberg's contributions to herpes virus research exemplify the importance of innovation in the medical field. His patent and collaborative efforts continue to influence the development of effective treatments and vaccines.